Upcoming Events

From parent advocate to nonprofit chief science officer, to biotherapeutic company cofounder — A personal journey through drug development for Angelman syndrome

Allyson Berent, DVM, DACVIM, COO and Cofounder, GeneTx Biotherapeutics

On May 29, 2020, Allyson Berent will discuss the journey that led her to becoming chief science officer of the largest research funding foundation for Angelman syndrome in the world (Foundation for Angelman Syndrome Therapeutics [FAST]), and the cofounder and chief operating officer of GeneTx Biotherapeutics — a biotech company solely focused on developing an antisense oligonucleotide for the treatment of Angelman syndrome — after her daughter was diagnosed with Angelman syndrome at 5.5 months old.

Past Events

Prevalence and trends in epidemiology of autism

Maureen Durkin, Ph.D., Dr.P.H.Professor of Population Health Sciences and Pediatrics, University of Wisconsin-Madison

On 25 March 2015, Maureen Durkin discussed trends in the prevalence of autism and explored some of the reasons underlying the recent rise in autism cases.

Subscribe to our newsletter and receive SFARI funding announcements and news